FDA Recalls Citroma Magnesium Citrate Laxative for Manufacturing Deviations
Vi-Jon is recalling Citroma magnesium citrate oral laxative due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects units distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary precautionary FDA Class II recall due to manufacturing process deviations. No specific safety hazard or adverse events are documented in the source material.
Plain-English summary
Vi-Jon, LLC is recalling Citroma magnesium citrate saline laxative oral solution due to Current Good Manufacturing Practice (CGMP) deviations. The recalled product is a 1.745 g magnesium citrate oral solution in 10 fl oz (296 mL) bottles with cherry flavor. This is an FDA Class II recall initiated voluntarily by the firm.
The recall affects approximately 10,070,526 units distributed nationwide in the United States, as well as Canada and Panama. The product was marketed under multiple store brands including Best Choice, Careone, CVS Health, Equaline, Equate, Family Wellness, GoodSense, H-E-B, Health Mart, Leader, Meijer, Premier Value, Publix, Quality Choice, Rexall, Rite Aid, Signature Care, Sunmark, Swan, TopCare, and Walgreens. All affected lots remain within their expiration dates.
The recall was initiated by the firm on July 15, 2022, and was terminated on May 9, 2024.
The recalled product
- Product
- CITROMA (MAGNESIUM CITRATE)
- Brand
- CITROMA
- Manufacturer
- Vi-Jon, LLC
- Category
- Drug — OTC Laxative
- Hazard
- Affected units
- 10,070,526
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
UPCs (26)
- 0846036009507
- 0321130789710
- 0072785143890
- 070038587903
- 341520000553
- 050428297339
- 050428285152
- 041163500686
- 681131287166
- 032251577888
- 846036007398
- 041220510870
- 052569142165
- 096295141061
- 096295141054
- 713733459440
- 840986035296
- 041415505735
- 635515901117
- 072785134164
- 011822433037
- 321130789710
- 010939910448
- 308690693381
- 036800455306
- 311917201580
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Vi-Jon, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same brand · CITROMA
- SevereFDA Recalls CITROMA Magnesium Citrate for Microbial Contamination
FDA (Drugs) · 2022-09-21
- CriticalFDA Recalls Citroma Magnesium Citrate Laxative for Microbial Contamination
FDA (Drugs) · 2022-09-21
- SevereOTC Magnesium Citrate Laxative Recalled for Microbial Contamination
FDA (Drugs) · 2022-09-21
- ModerateOTC Magnesium Citrate Laxative Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2022-09-21
Same manufacturer · Vi-Jon, LLC
See all →- ModerateKroger Mint Burst Antiseptic Mouth Rinse recalled for undeclared excipients
FDA (Drugs) · 2023-09-27
- SevereFDA Recalls Kroger Magnesium Citrate Laxative for Microbial Contamination
FDA (Drugs) · 2022-09-21
- SevereMagnesium Citrate Laxative Recalled Due to Microbial Contamination
FDA (Drugs) · 2022-09-21
- SevereSWAN Citroma Saline Laxative Recalled for Microbial Contamination
FDA (Drugs) · 2022-09-21
- CriticalCVS Health Magnesium Citrate Saline Laxative recalled for microbial contamination
FDA (Drugs) · 2022-09-21
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19